If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

AGM Trading Update

15 Dec 2017 07:00

RNS Number : 4370Z
Plant Impact PLC
15 December 2017
 

15 December 2017

Plant Impact plc

 

("Plant Impact", the "Company" or together with its subsidiaries, the "Group")

AGM Trading Update

Plant Impact plc (AIM: PIM), which leads research and development in crop enhancement technology to create products that growers can rely on to increase the yield and quality of their crops, will hold its Annual General Meeting ("AGM") today at 12.00 noon at the Rothamsted Conference Centre in Harpenden.

Ahead of the AGM, the Group announces the following trading update for the year to date. This update follows the announcement made on 13 December 2017 when the Company informed the market of important developments with Bayer CropScience ("BCS") and announced that it was evaluating all potential strategic options and entering a formal sales process. 

Operational update

Good progress continues to be made in the R&D activities of the Company. Since the start of the new financial year on 1 August 2017, four new compounds have completed lab and glasshouse assays in our early stage research work ("Discovery") and progressed to the next development stage. All four compounds show significant early yield indications and these compounds are now scheduled for more extensive development stage trials. One of the new compounds showed particular potential in our S1 seed treatment project and the other three showed promise as part of the F1 foliar spray project. 

Discovery work in collaboration with Ghent University is progressing well, with trials demonstrating that novel Pyrabactin analogues can control the aperture of leaf stomata and thereby reduce water loss. This intervention to improve the efficiency of a plant's water use could increase yield in drought conditions. 

Later stage R&D work includes important new trials underway in Brazil of the full portfolio of four individually proven soybean crop enhancement products and projects. For the first time, the combined effect of the full portfolio on soybean yield will be tested, targeting an uplift of over 15% in total yield improvement. Separate trials of S1 and F1 project formulations are also underway in Brazil and Argentina.

In Brazil, as announced on 13 December 2017, BCS has informed the Group that it will not be able to conclude a new contractual arrangement for Veritas® distribution until Q1 2018 at the earliest and that it will defer the purchase of further Veritas® volumes. Please refer to the Formal Sale Process paragraph below for further details.

Notwithstanding this recent development, we are continuing to work with BCS in the field in Brazil, to build the Veritas® business. Campaign activity is underway for the 2017/18 soybean and drybean growing season. The expectations of both ourselves and BCS are for good grower adoption of the product. Additionally, following trials of Veritas® on cotton plants in Brazil 2016/17, BCS intends to launch a commercial campaign for selected customers in the Mato Grosso and Bahia regions in 2018, which is based on proven yield uplifts of around 5 -7%, consistent with those seen in soybean.

In the USA, following the first season of product sales of Fortalis®, relationships with a network of key regional and national distributors are developing well, with coverage of every soybean-growing State already agreed for the 2018 US growing season.

In Argentina we are gearing up for the launch of the first full season of Fortalis® sales as a Plant Impact branded product. Arrangements are being put in place with local partners to provide distribution capability across the key soybean growing regions.

New partnership and product launch in Brazil

We are today announcing a new partnership with Albaugh Brazil ("Albaugh"). This partnership is separate to, and has no impact on, our relationship with BCS in Brazil to distribute Veritas®. Under a new distribution agreement, Albaugh will exclusively commercialize certain other Plant Impact technologies as Albaugh branded products, which will be offered through its extensive dealer network in Brazil targeting growers in the primary soybean, corn, cotton and coffee growing regions. The partnership will begin with the launch and regional test marketing of Fortiori®, a new Albaugh branded product based on a Plant Impact formulation. Fortiori® resolves a significant issue for growers due to "in-tank" antagonism between glyphosate herbicides and foliar-applied manganese nutrients.

Appointment of Interim Chief Financial Officer

The Board is pleased to announce that Ib Jensen today joins the Company in the non-Board position of Interim Chief Financial Officer and Company Secretary. Mr Jensen is a senior finance professional who has worked in a number of businesses and industries over a 25 year career. For the past ten years he has held a number of roles with Syngenta, the agricultural chemical multi-national, including four years from 2012 to 2016 based in Brazil as the CFO of its Latin American business. 

As previously announced on 6 October 2017, Richard Amos, the current CFO will be resigning from the Board at the conclusion of today's AGM. He will remain employed by the business until 9 February 2018 to ensure an efficient handover to Mr Jensen.

Formal Sale Process

The Company announced on 13 December 2017 that it had decided to investigate all potential strategic options for the business, including refinancing, potential divestment of selected assets or the sale of the Company. The Board has appointed Peel Hunt LLP as its financial adviser for this process, which includes the Company entering a formal sale process as referred to in the City Code on Takeovers and Mergers (the "Takeover Code").

As detailed in the 13 December 2017 announcement, the Company's reason for investigating all options is a consequence of BCS's decision to defer the purchase of further Veritas® volumes, which will have a material adverse effect on the Company's financial performance and on its cash resources.

Full details can be found in the 13 December 2017 announcement. At this time, there is no further update to that statement. 

 

For further information please contact:

Plant Impact plc

David Jones, Chairman

John Brubaker, Chief Executive Officer

Ailish Tracy, Global Communications Manager

 

 

Tel: +44 (0) 1582 465 540

 

Peel Hunt - Financial Adviser, Nominated Adviser and Broker

Adrian Trimmings

Michael Nicholson

George Sellar

Nicole McDougall

 

Buchanan - Financial PR

Mark Court

Sophie Wills

Jamie Hooper

Tel: +44 (0) 207 418 8900

 

 

 

Tel: +44 (0) 207 466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFSFFILSLID
Date   Source Headline
31st May 20118:30 amRNSTotal Voting Rights
24th May 20117:05 amRNS£2.05 million cash subscription by Arysta
24th May 20117:00 amRNSTrading update
6th Apr 20117:00 amRNSRule 17 disclosure
30th Mar 20118:30 amRNSHolding(s) in Company
11th Mar 20117:00 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSAppointment of new Chairman
30th Dec 20107:00 amRNSDirector/PDMR Shareholding
16th Dec 20109:50 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSHalf Yearly Report
24th Nov 201012:00 pmRNSHolding(s) in Company
18th Nov 20107:00 amRNSGrant of product registrations in Brazil
17th Nov 20107:00 amRNSDistribution and evaluation agreement
19th Oct 201010:30 amRNSHolding(s) in Company
23rd Sep 20107:00 amRNSEvaluation, Development and Distribution Agreement
26th Aug 201011:05 amRNSResult of AGM
25th Aug 20107:00 amRNSField Trials with Syngenta
12th Aug 20107:00 amRNSUpdated trial results
9th Aug 20107:00 amRNSGrant of Awards under LTIP and Share Options
5th Aug 20105:00 pmRNSPosting Annual Report and Accounts and AGM Notice
8th Jul 20102:20 pmRNSAppointment
14th Jun 20107:00 amRNSFinal Results
2nd Jun 20107:00 amRNSDistribution Agreement
29th Apr 20107:00 amRNSNotice of preliminary results and trading update
28th Apr 20107:00 amRNSField trial results
31st Mar 20103:30 pmRNSTotal Voting Rights
29th Mar 20102:46 pmRNSHolding(s) in Company
29th Mar 20102:45 pmRNSHolding(s) in Company
29th Mar 20102:30 pmRNSHolding(s) in Company
12th Mar 201011:15 amRNSResult of General Meeting
25th Feb 20107:00 amRNSIssue of Equity
8th Feb 20107:00 amRNSArysta agreement
3rd Feb 20107:00 amRNSPiNT study results
18th Jan 20107:00 amRNSFinalist at 2010 Grower of the Year Awards
6th Jan 20103:15 pmRNSDirectorate Change
6th Jan 201012:40 pmRNSChange of Adviser
7th Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200911:31 amRNSFurther Field Trial Results
22nd Oct 20097:00 amRNSAward of EU research grant
28th Sep 20097:00 amRNSTrading Statement
10th Sep 200910:36 amRNSHolding(s) in Company
10th Sep 200910:32 amRNSHolding(s) in Company
7th Sep 20098:31 amRNSNew Scientific Advisory Board Announcement
13th Aug 20098:41 amRNSSuccessful Application to Join Committee
6th Aug 20093:58 pmRNSGrant of Options
3rd Aug 20095:15 pmRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
31st Jul 200912:00 pmRNSTotal Voting Rights
30th Jul 200910:20 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.